According to the present clinical guideline, several drug delivery systems were applied among patients, including liposomes (38, 39) were used as drug-nanocarriers for treating ovarian cancer or other carcinomas so as to improve the drug delivery efficiency and reduce side effects, albumin-bound paclitaxel (40, 41) was used to increase the stability via albumin modification. Here, ALB is linked to ovarian cancer.